4.2 Article

Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset

期刊

NEUROMUSCULAR DISORDERS
卷 20, 期 1, 页码 53-56

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2009.10.006

关键词

DNM2; Dynamin 2; Pleckstrin homology; GTPase; Mutation; Congenital myopathy; Centronuclear myopathy; Myotubular myopathy; Charcot-Marie-Tooth neuropathy; Myotubularin; Amphiphysin; RYR1; Neonatal

资金

  1. Selander foundation
  2. Uppsala University Hospital
  3. Helsinki University Hospital
  4. Sigrid Juselius Foundation
  5. Academy of Finland
  6. Association Francaise contre les Myopathies (AFM)
  7. Finska Lakaresallskapet
  8. Medicinska understodsforeningen Liv och Halsa
  9. Fondation Recherche Medicale
  10. GIS Institut Maladies Rares
  11. Agence Nationale de la Recherche

向作者/读者索取更多资源

We report a family with autosomal dominant centronuclear (myotubular) myopathy caused by a novel mutation, p.A618D, in dynamin 2 (DNM2). The 64-year-old mother and 26-year-old daughter had neonatal onset with hypotonia and weak suckling, followed by improvement, then slowly progressive muscle weakness and respiratory restriction. Muscle biopsy showed radial sarcoplasmic strands around the frequent central nuclei. Electrophysiology revealed predominantly myopathic patterns without peripheral nerve involvement. Centronuclear myopathy with neonatal onset caused by a DNM2 mutation in the C-terminal part of the pleckstrin homology domain may have a favorable prognosis and follow a course similar to adult-onset centronuclear myopathy. We advise respiratory follow-up in these patients. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据